• Vitamin D deficiency is widespread.
• Vitamin D deficiency is widespread.
• Vitamin D is probably involved in the prevention of numerous disease states.
• Most primary care clinicians are unaware of the recommended dose for vitamin D supplementation or the optimum serum level in multiple sclerosis (MS) patients.
• In the general population management of vitamin D deficiency in children and adults can be effectively achieved by administering 50,000 IU vitamin D2 or vitamin D3 once a week for 6 or 8 weeks respectively: • Considerable evidence exists for the protective effects of vitamin D in MS, with higher sun exposure and vitamin D intake associated with a lower risk of MS.
• Improvement in 25(OH)D status appears to additively enhance the beneficial effects of interferon-beta. To date, this effect has not as yet been observed with glatiramer acetate.
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